The Biden administration said Thursday that it had reached an agreement with drugmakers to lower prices on the 10 costliest prescription drugs under Medicare. It's part of the federal government's ...
The residential real estate market is slowly shaking off the cobwebs of a sluggish year of buying and selling, and quick-thinking homebuyers stand a good chance of snapping up a property at a lower ...
Nearly half of U.S. home sellers have cut prices this fall, with a median markdown of 4%. Median list prices hold steady as days on market edge higher. AI Summary The fall housing market is sending a ...
Home prices have climbed at a historic pace in the United States in recent years. According to the Case-Shiller U.S. National Home Price Index, a typical single-family home is now about 50% more ...
Share on Pinterest Medicare has negotiated price cuts ranging from 38% to 79% for 10 common prescription drugs. Maskot/Getty Images Medicare announced negotiated prices for 10 prescription drugs, ...
It’s no secret that prices have increased in the last decade — especially for healthcare. And as new economic policies like tariffs take effect, we can expect consumer out-of-pocket costs to continue ...
Since the start of the COVID-19 pandemic, supply and demand dynamics have sent home prices surging by nearly 38% nationwide and about 35% in Georgia. But location matters in the U.S. housing market, ...
Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday. The ...
The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency" to ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price hikes, ...